NASDAQ:AURA | Cash Flow Statement | Aura Biosciences, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$45.64M
2026-03-31-$33.69M-$29.89M$102,000.00$54.9M$300,000.00
2025-12-31-$25.56M-$20.47M$176,000.00$29.82M$2.77M
2025-09-30-$26.13M
2025-06-30-$27.02M
2025-03-31-$27.48M-$23.36M$187,000.00$29.81M$96,000.00
2024-12-31-$25.83M-$23.95M$299,000.00$29.7M$543,000.00
2024-09-30-$21.04M
2024-06-30-$20.34M
2024-03-31-$19.71M-$24.45M$88,000.00$9.4M$253,000.00
2023-12-31-$22.13M-$17.39M$317,000.00-$90.12M$92.99M
2023-09-30-$18.51M
2023-06-30-$18.3M
2023-03-31-$17.47M-$16.41M$109,000.00-$66.88M$201,000.00
2022-12-31-$16.56M-$18.01M$358,000.00-$16.88M$95.2M
2022-09-30-$15.9M
2022-06-30-$13.47M
2022-03-31-$12.84M-$15.2M$599,000.00-$25.5M$17,000.00
2021-12-31-$11.63M-$12.09M$819,000.00-$819,000.00$80.14M
2021-09-30-$8.84M
2021-06-30-$8.85M
2021-03-31-$5.93M-$5.14M$71,000.00-$71,000.00$87.49M
2020-12-31-$4.91M-$3.76M$132,000.00-$132,000.00$5.13M
2020-09-30-$3.63M
2020-06-30-$6.16M
2020-03-31-$7.51M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$106.19M-$84.74M$447,000.00$35.6M$77.16M
2024-12-31-$86.92M-$79.81M$1.25M$68.82M$1.6M
2023-12-31-$76.41M-$63.85M$709,000.00-$113.96M$97.29M
2022-12-31-$58.76M-$54.6M$1.09M-$67.87M$95.63M
2021-12-31-$35.25M-$32.41M$2.13M-$2.13M$166.26M
2020-12-31-$22.21M-$24.32M$771,000.00-$771,000.00$10.04M